FDA Issues Final Guidance on New Review Path for Safer Technologies

The FDA is introducing a new review program for medical devices and device-led combination products that are expected to significantly improve the safety of treatments for a disease or condition deemed less serious than those eligible for the breakthrough devices program.
Source: The GMP Letter